COBEA PHARMA
Board
1 director, last change in 2023Director (not named in the articles), permanent representative
appointed by deed of 25-05-2023
earlier manager, until 25-05-2023
listed in the 2026 annual accounts, filed on 24-09-2026
Permanent representatives 1
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Director (not named in the articles), since before 31-03-2022
- Manager, until 25-05-2023
Control
Parent
Equity €561,064
Profit €56,152 in 2026 (profit €69,695 in 2025)
Source: accounts 31-03-2026
100%
This company
COBEA PHARMA
Equity €146,454
Profit €9,378 in 2026
Capital
- Contribution
- €18,600
- Source
- 2026 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
-
- 2014 to 2026: 100%
Source: lists of holdings in the owners' accounts
Articles of association
deed of 25-05-2023 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Moitié cédant,moitié acquéreurs au prorata, cessions entre vifs à titre onéreux ou gratuit,volontaires ou forcées,y compris exclusion et…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- 31 August at 17:00